DalsnaFinance › IPOs › Xeris Biopharma Holdings Inc › IPO
XERIS PHARMACEUTICALS INC completed its initial public offering on NASDAQ on June 21, 2018, pricing at $15.00 a share.
| Ticker | XERS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 21, 2018 |
| Offering price | $15.00 |
| Shares offered | 5,700,000 |
| Total raised | $86M |
XERIS PHARMACEUTICALS INC sold 5,700,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $85.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $86 million total recorded for the deal.
XERIS PHARMACEUTICALS INC — quote, profile and latest news →
Source: SEC EDGAR filings for XERIS PHARMACEUTICALS INC. This page is general information, not investment advice.